EBITDA: Income before interest, taxes, depreciation and amortization.
NovelStem International Corp. (NSTM) had EBITDA of $-0.18M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$2.38M |
|
-- |
|
-- |
|
$0.24M |
|
$-0.24M |
|
$2.61M |
|
$2.37M |
|
$2.37M |
|
$2.37M |
|
$2.38M |
|
$2.38M |
|
$2.37M |
|
$-0.24M |
|
|
EBITDA |
$-0.18M |
46.88M |
|
47.80M |
|
$0.05 |
|
$0.05 |
|
| Balance Sheet Financials | |
$0.02M |
|
-- |
|
-- |
|
$0.02M |
|
$2.16M |
|
-- |
|
-- |
|
$2.16M |
|
$-2.14M |
|
$-2.14M |
|
$-2.14M |
|
46.88M |
|
| Cash Flow Statement Financials | |
$-0.17M |
|
-- |
|
$0.16M |
|
$0.01M |
|
$0.00M |
|
$-0.01M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-- |
|
-0.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-111.12% |
|
-111.12% |
|
15075.90% |
|
-111.12% |
|
$-0.05 |
|
$-0.00 |
|
$-0.00 |
|